Available Forms: Injection
Available Strengths: 30 mg/mL
Reference Brands: Feraheme (USA)
Category: Anemia
Ferumoxytol is an intravenous iron replacement therapy used to treat iron deficiency anemia, especially in adults with chronic kidney disease. It is available as a 30 mg/mL IV solution, supplied in 17 mL vials (510 mg elemental iron). In the USA, both brand and generic versions are available. Ferumoxytol Injection is available in Injection and strengths such as 30 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ferumoxytol Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Ferumoxytol Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Quick Response Guaranteed | Verified Suppliers
Ferumoxytol is used to treat iron deficiency anemia, particularly in adults with chronic kidney disease. It helps increase hemoglobin levels by rapidly replenishing iron stores in the body and is often used when oral iron is not effective or not tolerated.
Ferumoxytol is made from superparamagnetic iron oxide nanoparticles coated with a carbohydrate shell. This structure allows controlled iron release and reduces the risk of free iron toxicity while improving absorption.
Ferumoxytol is marketed under the trade name Feraheme in many regions. Brand names may differ slightly depending on the market.
Ferumoxytol is manufactured by AMAG Pharmaceuticals, with additional licensed manufacturers supplying certain global markets.
The generic name of the product is ferumoxytol.
The main brand name for ferumoxytol is Feraheme, depending on the country and manufacturer.
Ferumoxytol is manufactured in the United States and other approved pharmaceutical facilities depending on the licensed producer. The specific manufacturing site varies by company and region.
Strength: 12.5 mg, 25 mg, 50 mg, and 75 mg
Form: Tablets / Oral suspension
Reference Brands: Promacta (USA), Revolade (EU)
Strength: 1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
Strength: 500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
Strength: 125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under ‘Fair use.’
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.